W
WAVEMAN · COMPANY
GNTA · Genenta Science S.P.A.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

GNTA

Genenta Science S.p.A.
PHARMA & BIOTECH · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · CIK 0001838716
ACTIVIST 13D☆ WATCH
INSIDER NET · 180D
-
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
3
13F, latest reported quarter
REVENUE GROWTH
-
XBRL, annual
NET MARGIN
-
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
no Form 4 purchases or sales on file
CONGRESS
no member of Congress has reported trading it
FUNDS
3 funds added or opened last quarter
below 98% of Pharma & Biotech
REVENUE
no revenue reported in any filing
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
no share repurchases reported
SHORT
0.6% of shares outstanding short · 1.9 days to cover · settled 2026-07-31
below 76% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Marco Nuzzo disclosed a 5%+ stake (23.0%) in the last six months.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -72.8%
-72.8%12M
-84%-30%+23%+76%2025-092025-102025-122026-032026-052026-072026-09 2026-05-05 · Marco Nuzzo filed a 5%+ stake (23.0%)2026-05-05 · Luigi Naldini filed a 5%+ stake (23.0%)2026-05-05 · Bernhard Gentner filed a 5%+ stake (23.0%)2026-05-05 · Globe 2017 S.r.l. filed a 5%+ stake (23.0%)2026-05-05 · Ferragamo Finanziaria S.p.A. filed a 5%+ stake (23.0%)2026-05-05 · Gaudenzio Roveda filed a 5%+ stake (23.0%)2026-05-05 · Fidim S.p.A. filed a 5%+ stake (23.0%)2026-05-05 · Fin Posillipo S.p.A. filed a 5%+ stake (23.0%)2026-05-05 · BF & F S.r.l. filed a 5%+ stake (23.0%)2026-05-05 · Vyoda S.r.l. filed a 5%+ stake (23.0%)2026-05-05 · Vittorio Avogadro di Collobiano filed a 5%+ stake (23.0%)
13D/G STAKE
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
An activist crossed the 5% line with declared intent.
The record shows 3 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for Genenta Science S.p.A. in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE

no insider purchases or sales on record

0 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Eurizon Capital SGR S.p.A.
360,000.0 sh
$662.4K
Allianz SE
234,050.0 sh
$430.7K
SmartHarvest Portfolios, LLC
43,856.0 sh
$80.7K
Simplicity Wealth,LLC
18,590.0 sh
$34.2K
Ground Swell Capital, LLC
14,374.0 sh
$26.4K
5%+ owners
13D = intent to influence · 13G = passive
Marco Nuzzo
ACTIVIST 13D · 2026-05-05
23.0%
Luigi Naldini
ACTIVIST 13D · 2026-05-05
23.0%
Bernhard Gentner
ACTIVIST 13D · 2026-05-05
23.0%
Globe 2017 S.r.l.
ACTIVIST 13D · 2026-05-05
23.0%
Ferragamo Finanziaria S.p.A.
ACTIVIST 13D · 2026-05-05
23.0%
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
OPERATING INCOME$-6.6M$-9.8M$-11.7M$-11.0M
NET INCOME$-6.5M$-8.9M$-11.6M$-8.5M
EPS (DILUTED)-0.33-0.49-0.64-0.47
OPERATING CASH FLOW$-6.9M$-6.2M$-11.2M$-7.4M
CASH$5.5M$4.6M$3.7M$29.8M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →